Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. De Backer (Kontich, Belgium). Late Breaking Abstract - Assessment of disease progression in IPF patients using Functional Respiratory Imaging (FRI). 1952

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Assessment of disease progression in systemic sclerosis-associated interstitial lung disease (SSc-ILD) patients using Functional Respiratory Imaging (FRI) Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Late Breaking Abstract - COVID-19 Infodemic and Health-Related Quality of Life (HRQoL) in Patients with Chronic Respiratory Diseases (CRDs) Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 LATE-BREAKING ABSTRACT: Daytime motor activity and emphysema on CT: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung and Sleep Studies Source: International Congress 2014 – Mechanisms of exercise limitation in disease Year: 2014 Late Breaking Abstract - Functional Respiratory Imaging (FRI) and machine learning to predict organ rejection shortly after lung transplantation Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019 Late Breaking Abstract - Fully automated airway measurement correlates with radiological disease progression in Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Remote monitoring of respiratory patients Year: 2021 Late Breaking Abstract - Lung ultrasound for severity assessment and outcome prediction of COVID-19 patients. Source: Virtual Congress 2020 – Transthoracic and endobronchial ultrasound Year: 2020 Prediction of IPF Progression Using HRCT Imaging Patterns in Elderly Population Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Late Breaking Abstract - Patient Reported Outcomes (PRO) Correlate Better with Intra-Breath than with Whole-Breath FOT Parameters. Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Late Breaking Abstract - Lung deflation with Indacaterol/Glycopyrronium improves cardiac function in COPD patients: The CLAIM Study Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Relationship Between Lung Functions and Extent of Emphysema as Assessed by High-Resolution Computed Tomography in Patients With COPD Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Late Breaking Abstract - Correlation of CT severity score and Inflammatory markers to predict the disease severity in COVID 19 patients Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021 Late Breaking Abstract - Bronchoscopic Thermal Vapor Ablation (BTVA) Outcomes at 12 months in Emphysema Patients with Severe Hyperinflation, a STEP-UP RCT Subgroup Analysis Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Cytomegalovirus reactivation in COVID-19 patients with Acute Respiratory Distress Syndrome. Source: Virtual Congress 2021 – Severe acute respiratory failure Year: 2021 Cell Therapy in Patients with Advanced Chronic Obstructive Pulmonary Disease:  3 and 6 months follow up of Six Minute Walk Test, Quality of life and Pulmonary Function Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017